Datasets:

rahul77

/

LaTeX3

like 0

\begin{table} \centering \begin{tabular}{|l||l||l||l||l||l||l||l|} \hline SNP & Series & Rare-allele & Common & Heterozygote & Rare & Number & P \\ \hline SNP & Cases & 0.13 & 1618 & 447 & 42 & 2107 \\ \hline & Controls & 0.13 & 1645 & 511 & 33 & 2189 & 0.13 \\ \hline & OR & & 1 & 0.89 & 1.29 \\ \hline SNP & Cases & 0.25 & 1151 & 734 & 140 & 2025 \\ \hline & Controls & 0.26 & 1219 & 839 & 147 & 2205 & 0.48 \\ \hline & OR & & 1 & 0.93 & 1.01 \\ \hline SNP & Cases & 0.32 & 962 & 855 & 219 & 2036 \\ \hline & Controls & 0.32 & 1022 & 956 & 230 & 2208 & 0.69 \\ \hline & OR & & 1 & 0.95 & 1.01 \\ \hline SNP & Cases & 0.25 & 1128 & 748 & 113 & 1989 \\ \hline & Controls & 0.25 & 1230 & 791 & 134 & 2155 & 0.69 \\ \hline & OR & & 1 & 1.03 & 0.92 \\ \hline SNP & Cases & 0.33 & 911 & 870 & 233 & 2014 \\ \hline & Controls & 0.33 & 960 & 983 & 238 & 2181 & 0.45 \\ \hline & OR & & 1 & 0.93 & 1.03 \\ \hline \end{tabular} \end{table}

\begin{table} \centering \begin{tabular}{|l||l||l|} \hline Parameter & Total & Evaluations \\ \hline Number & 219 & 38 \\ \hline Tracheostomy & 59 & 10 \\ \hline Atelectasisa & 13 & 6 \\ \hline Lung & 35 & 9 \\ \hline Lung & 6 & 1 \\ \hline Pleural & 21 & 8 \\ \hline Previous & 30 & 6 \\ \hline COPD & 16 & 3 \\ \hline Cancer & 11 & 2 \\ \hline Asthma & 2 & 1 \\ \hline Pulmonary & 1 & None \\ \hline Broncoaspiration & 12 & 3 \\ \hline Sepsis & 46 & 14 \\ \hline ARDS & 12 & 3 \\ \hline (n & 91 & 20 \\ \hline Diabetes & 35 & 5 \\ \hline Chemotherapy & 13 & 2 \\ \hline Radiotherapy & 2 & None \\ \hline Immunossupressants & 5 & 1 \\ \hline AIDS & 3 & None \\ \hline Renal & 5 & 1 \\ \hline (n & 32 & 7 \\ \hline Multiple & 21 & 3 \\ \hline Neuromuscular & 7 & 7 \\ \hline Central & 215 & 38 \\ \hline Intracranial & 20 & 1 \\ \hline \end{tabular} \end{table}

\begin{table} \centering \begin{tabular}{|l||l||l||l||l||l||l|} \hline Registration & Priority & 1 & Priority & 2 & Priority & 3 \\ \hline & HR & (95% & HR & (95% & HR & (95% \\ \hline 1991–1992 & 1.00 & referent & 1.00 & referent & 1.00 & referent \\ \hline 1993–1994 & 0.79 & (0.57, & 1.10 & (1.01, & 0.78 & (0.65, \\ \hline 1995–1996 & 0.66 & (0.50, & 0.71 & (0.65, & 0.69 & (0.58, \\ \hline 1997–1998 & 0.49 & (0.36, & 0.82 & (0.75, & 0.75 & (0.63, \\ \hline 1999–2000 & 0.47 & (0.33, & 0.99 & (0.90, & 1.07 & (0.90, \\ \hline \end{tabular} \end{table}

\begin{table} \centering \begin{tabular}{|l||l||l||l|} \hline Period & Mean & Lower & Upper \\ \hline Before & 18.4 & 17.8 & 19.0 \\ \hline After & 18.6 & 18.1 & 19.1 \\ \hline \end{tabular} \end{table}

\begin{table} \centering \begin{tabular}{|l||l||l||l|} \hline & Mean & Std. & N \\ \hline change & .30 & 1.80 & 22 \\ \hline change & .84 & .92 & 22 \\ \hline change & .17 & 1.09 & 22 \\ \hline \end{tabular} \end{table}

\begin{table} \centering \begin{tabular}{|l||l||l||l|} \hline Part & a \\ \hline Organism & Genome & No. & Genome \\ \hline Corynebacterium & 2.5 & 3 & NC_002935 \\ \hline Corynebavterium & 3.3 & 2 & NC_003450 \\ \hline Corynebacterium & 3.1 & 2 & NC_004369 \\ \hline Micrococcus & 2.3 & 1 & Mukamolova \\ \hline Mycobacterium & 4.7 & 4 & NC_002944 \\ \hline Mycobacterium & 4.3 & 5 & NC_002945 \\ \hline Mycobacterium & 3.3 & 3 & NC_002677 \\ \hline Mycobacterium & 6.5 & 4 & NC_004506 \\ \hline Mycobacterium & 7.0 & 4 & NC_002974 \\ \hline Mycobacterium & 4.4 & 5 & NC_000962 \\ \hline Streptomyces & 8. & 5 & NC_003888 \\ \hline Streptomyces & 9.0 & 6 & NC_003155 \\ \hline Part & a & to \\ \hline Bifidobacterium & 2.3 & 3 & NC_004307 \\ \hline Tropheryma & 0.9 & 2 & NC_004572 \\ \hline Streptomyces & 8. & 2 & NC_003888 \\ \hline Streptomyces & 9.0 & 3 & NC_003155 \\ \hline Staphylococcus & - & 2 & - \\ \hline Staphylococcus & 2.8 & 1 & NC_002745 \\ \hline Staphylococcus & 2.6 & 1 & NC_004461 \\ \hline Oenococcus & 0.3 & 1 & NZ_AABJ02000001 \\ \hline \end{tabular} \end{table}

\begin{table} \centering \begin{tabular}{|l||l||l||l||l|} \hline Variable & Study & 2001–2003 & STS & P-Value \\ \hline No. & 504 & & 448841 \\ \hline Demographics/Risk \\ \hline Age & 64 & 65 & 66 \\ \hline Male & 368 & 73.0 & 71.3 & .433 \\ \hline Caucasian & 474 & 94.0 & 87.1 & <.001 \\ \hline Black & 5 & 1 & 5.17 & <.001 \\ \hline Hispanic/Other & 25 & 4.96 & 6.84 \\ \hline BSA & 2.08 & 2.08 & 1.95 & <.001 \\ \hline Obese & 103 & 20.4 & 13.4 & <.001 \\ \hline Current & 101 & 20 & 22.1 & .295 \\ \hline Family & 403 & 80 & 43.2 & <.001 \\ \hline Diabetes & 168 & 33.30 & 35.0 & .469 \\ \hline Insulin-dependent & 41 & 8.13 & 10.47 & .102 \\ \hline Hypercholesterolemia & 323 & 64 & 68.49 & .038 \\ \hline Renal & 10 & 1.98 & 5.20 & .002 \\ \hline Hypertension & 358 & 71 & 74.78 & .060 \\ \hline Peripheral & 35 & 6.94 & 15.80 & <.001 \\ \hline Cerebrovascular & 60 & 11.90 & 13.21 & .425 \\ \hline COPD & 68 & 13.50 & 18.61 & .004 \\ \hline Myocardial & 266 & 52.80 & 45.53 & <.001 \\ \hline Congestive & 44 & 8.73 & 13.80 & <.001 \\ \hline Unstable & 222 & 44.10 & 47.05 & .193 \\ \hline Arrhythmia & 42 & 8.30 & 9.43 & .443 \\ \hline Triple & 422 & 83.70 & 74.63 & <.001 \\ \hline Left & 118 & 23.40 & 24.54 & .594 \\ \hline Ejection & 48 & 50 & 50 \\ \hline Previous & 116 & 23.00 & 20.36 & .155 \\ \hline Operative \\ \hline Elective & 129 & 25.60 & 51.88 & <.001 \\ \hline Emergent & 63 & 12.50 & 4.10 & <.001 \\ \hline Redo & 15 & 2.98 & 8.93 & <.001 \\ \hline No. & 3.58 \\ \hline Arterial & 1.63 \\ \hline Vein & 1.94 \\ \hline ITA & 473 & 93.80 & 89.84 & .004 \\ \hline Left & 471 & 93.50 & 89.34 & .004 \\ \hline Aortic & 58 & 55 & 63 & .004 \\ \hline Perfusion & 90 & 85 & 94 \\ \hline Off-pump & 21 & 4.17 & 20.48 & <.001 \\ \hline STS & 2.94 & & 3.13 \\ \hline \end{tabular} \end{table}

\begin{table} \centering \begin{tabular}{|l||l||l||l||l||l||l||l||l||l||l||l||l|} \hline & Markersa & & Positionsb & & Human & & Mean & & Maximum & & Marker \\ \hline BTA & New & Otherh & New & Other & New & Other & New & Other & New & Other & New & Other \\ \hline 1 & 28 & 263 & 21 & 150 & 18 & 30 & 6.8 & 1.1 & 59.3 & 5.7 & 1.9 & .9 \\ \hline 2 & 39 & 188 & 31 & 112 & 33 & 34 & 4.4 & 1.2 & 17.5 & 6.3 & .9 & .9 \\ \hline 3 & 45 & 174 & 29 & 99 & 37 & 25 & 4.2 & 1.3 & 16.5 & 5.4 & 1.1 & .8 \\ \hline 4 & 28 & 131 & 18 & 82 & 21 & 21 & 6.1 & 1.5 & 16.2 & 4.6 & .7 & .7 \\ \hline 5 & 62 & 185 & 36 & 114 & 40 & 37 & 3.8 & 1.3 & 22.8 & 4.7 & 1.3 & .8 \\ \hline 6 & 15 & 230 & 14 & 115 & 7 & 35 & 8.6 & 1.2 & 16.7 & 9.1 & .6 & 1.0 \\ \hline 7 & 45 & 142 & 28 & 88 & 39 & 31 & 4.6 & 1.6 & 34.3 & 8.5 & 1.5 & .9 \\ \hline 8 & 24 & 125 & 21 & 85 & 19 & 11 & 5.6 & 1.6 & 18.5 & 7.9 & .9 & 1.0 \\ \hline 9 & 5 & 126 & 5 & 79 & 5 & 10 & 16.3 & 1.5 & 42.7 & 4.9 & 1.1 & .8 \\ \hline 10 & 39 & 131 & 24 & 87 & 34 & 25 & 3.7 & 1.4 & 8.6 & 3.8 & .7 & .7 \\ \hline 11 & 28 & 199 & 22 & 106 & 23 & 28 & 5.4 & 1.3 & 35.5 & 7.6 & 1.6 & 1.0 \\ \hline 12 & 4 & 122 & 4 & 79 & 3 & 10 & 22.9 & 1.4 & 47.9 & 8.9 & 1.0 & .9 \\ \hline 13 & 26 & 116 & 17 & 75 & 21 & 17 & 3.9 & 1.4 & 12.1 & 4.9 & .9 & .7 \\ \hline 14 & 6 & 133 & 6 & 77 & 6 & 21 & 18.0 & 1.4 & 49.5 & 5.1 & 1.2 & .9 \\ \hline 15 & 28 & 145 & 19 & 92 & 27 & 38 & 5.5 & 1.2 & 16.4 & 5.6 & .9 & .9 \\ \hline 16 & 27 & 101 & 20 & 66 & 19 & 6 & 4.7 & 1.5 & 28.5 & 5.2 & 1.3 & .7 \\ \hline 17 & 23 & 107 & 15 & 70 & 16 & 15 & 6.5 & 1.4 & 24.4 & 5.5 & 1.1 & .7 \\ \hline 18 & 49 & 114 & 27 & 69 & 39 & 20 & 2.7 & 1.3 & 10.8 & 5.3 & .9 & .8 \\ \hline 19 & 39 & 166 & 32 & 94 & 32 & 81 & 2.4 & 1.2 & 12.7 & 6.7 & 1.2 & 1.1 \\ \hline 20 & 11 & 119 & 8 & 64 & 8 & 12 & 6.8 & 1.3 & 16.1 & 5.2 & .8 & .8 \\ \hline 21 & 20 & 123 & 16 & 71 & 19 & 15 & 4.8 & 1.2 & 26.3 & 4.0 & 1.5 & .7 \\ \hline 22 & 25 & 84 & 12 & 57 & 20 & 21 & 5.4 & 1.6 & 18.7 & 7.2 & 1.1 & .8 \\ \hline 23 & 29 & 84 & 16 & 46 & 25 & 29 & 5.0 & 1.8 & 30.8 & 6.3 & 1.6 & .7 \\ \hline 24 & 10 & 95 & 8 & 62 & 7 & 9 & 9.5 & 1.3 & 17.3 & 3.8 & .6 & .6 \\ \hline 25 & 29 & 74 & 25 & 51 & 21 & 12 & 2.7 & 1.4 & 11.3 & 7.1 & 1.3 & 1.1 \\ \hline 26 & 12 & 64 & 4 & 44 & 11 & 8 & 9.4 & 1.9 & 14.5 & 7.2 & .6 & .9 \\ \hline 27 & 5 & 72 & 5 & 41 & 1 & 6 & 10.5 & 1.7 & 15.9 & 6.2 & .5 & .8 \\ \hline 28 & 9 & 79 & 9 & 44 & 7 & 10 & 5.7 & 1.4 & 19.0 & 4.7 & 1.0 & .7 \\ \hline 29 & 25 & 158 & 19 & 80 & 24 & 27 & 2.8 & .9 & 13.6 & 3.3 & 1.2 & .8 \\ \hline \end{tabular} \end{table}

\begin{table} \centering \begin{tabular}{|l||l||l||l||l||l||l|} \hline Patients & Nucleotides & Number & Total & Number & Expressed & OA \\ \hline Fibroblasts \\ \hline OA & 10971 & 36 & 3.281 & 24 & 2.188 \\ \hline RA & 7317 & 15 & 2.050 & 10 & 1.367 & ρ \\ \hline Tissue \\ \hline OA & 18287 & 32 & 1.750 & 15 & 0.820 \\ \hline RA & 24522 & 41 & 1.672 & 21 & 0.856 & ρ \\ \hline \end{tabular} \end{table}

\begin{table} \centering \begin{tabular}{|l||l||l||l||l||l||l||l||l||l||l||l||l||l|} \hline & & Initiative & Power & Social & & Mental & & Motility & & Physical & & Digestive & Well- \\ \hline & & long & short & long & short & Long & short & long & short & long & Short & long & short \\ \hline SF-36 & PF & 0.200 & 0.130 & 0.219 & 0.188 & 0.233 & 0.173 & 0.551 & 0.580 & 0.432 & * & 0.167 & * \\ \hline & RP & 0.234 & 0.178 & 0.252 & 0.226 & 0.294 & 0.257 & 0.461 & 0.453 & 0.403 & * & 0.184 & * \\ \hline & BP & 0.182 & 0.147 & 0.213 & 0.198 & 0.301 & 0.242 & 0.449 & 0.466 & 0.688 & * & 0.183 & * \\ \hline & GH & 0.358 & 0.288 & 0.363 & 0.308 & 0.361 & 0.322 & 0.353 & 0.332 & 0.350 & * & 0.208 & * \\ \hline & VT & 0.562 & 0.470 & 0.532 & 0.479 & 0.668 & 0.582 & 0.541 & 0.478 & 0.408 & * & 0.353 & * \\ \hline & SF & 0.543 & 0.437 & 0.632 & 0.589 & 0.550 & 0.486 & 0.392 & 0.342 & 0.337 & * & 0.324 & * \\ \hline & RE & 0.452 & 0.380 & 0.497 & 0.418 & 0.428 & 0.423 & 0.264 & 0.215 & 0.259 & * & 0.243 & * \\ \hline & MH & 0.650 & 0.543 & 0.686 & 0.605 & 0.719 & 0.690 & 0.378 & 0.316 & 0.324 & * & 0.360 & * \\ \hline & MCS & 0.650 & 0.548 & 0.698 & 0.615 & 0.667 & 0.640 & 0.294 & 0.213 & 0.245 & * & 0.348 & * \\ \hline & PCS & 0.020 & -0.012 & 0.022 & 0.025 & 0.087 & 0.024 & 0.489 & 0.530 & 0.497 & * & 0.089 & * \\ \hline GBB & SE & 0.458 & 0.363 & 0.513 & 0.457 & 0.626 & 0.546 & 0.559 & 0.496 & 0.387 & * & 0.323 & * \\ \hline & GS & 0.216 & 0.189 & 0.266 & 0.227 & 0.303 & 0.247 & 0.205 & 0.166 & 0.238 & * & 0.356 & * \\ \hline & LP & 0.249 & 0.201 & 0.296 & 0.263 & 0.386 & 0.312 & 0.490 & 0.498 & 0.514 & * & 0.190 & * \\ \hline & HS & 0.305 & 0.249 & 0.360 & 0.285 & 0.372 & 0.342 & 0.282 & 0.252 & 0.248 & * & 0.309 & * \\ \hline Bf-S & & 0.655 & 0.564 & 0.652 & 0.599 & 0.630 & 0.581 & 0.409 & 0.362 & 0.312 & * & 0.339 & * \\ \hline SES & AFF & 0.289 & 0.231 & 0.314 & 0.277 & 0.371 & 0.325 & 0.374 & 0.372 & 0.506 & * & 0.183 & * \\ \hline & SENS & 0.181 & 0.143 & 0.228 & 0.215 & 0.254 & 0.209 & 0.288 & 0.299 & 0.417 & * & 0.147 & * \\ \hline HLQ- & PWB & 0.357 & 0.270 & 0.335 & 0.333 & 0.489 & 0.412 & 0.929 & 0.958 & 0.638 & * & 0.259 & * \\ \hline & VIT & 0.577 & 0.502 & 0.590 & 0.523 & 0.840 & 0.681 & 0.611 & 0.517 & 0.560 & * & 0.661 & * \\ \hline & MEB & 0.894 & 0.822 & 0.772 & 0.702 & 0.797 & 0.770 & 0.471 & 0.401 & 0.278 & * & 0.412 & * \\ \hline & PERS & 0.926 & 0.779 & 0.760 & 0.734 & 0.628 & 0.584 & 0.404 & 0.354 & 0.226 & * & 0.342 & * \\ \hline & SOC & 0.748 & 0.697 & 0.923 & 0.860 & 0.600 & 0.573 & 0.358 & 0.346 & 0.248 & * & 0.346 & * \\ \hline \end{tabular} \end{table}

\begin{table} \centering \begin{tabular}{|l||l||l|} \hline & Waiting & Not \\ \hline & (N & (N \\ \hline Men & 7 & 5 \\ \hline Women & 4 & 7 \\ \hline Mean & 3.6 & 5.7 \\ \hline Mean & 34.4 & 36.8 \\ \hline Psychotic & 11 & 8 \\ \hline §according \\ \hline §2-1 & 1 & 3 \\ \hline §3-6 & 5 & 3 \\ \hline §3-3 & 5 & 6 \\ \hline §as \\ \hline §2-1 & 1 & 3 \\ \hline §3-6 & 3 & 3 \\ \hline §3-3 & 7 & 6 \\ \hline \end{tabular} \end{table}

\begin{table} \centering \begin{tabular}{|l||l||l||l||l||l||l||l||l|} \hline Feature & ChARM & Caryo-scope & TreeView & SeeGH & CGH & CGH & CGH & CGH \\ \hline Platform & most & most & most & Windows & most & most & Linux, & Windows, \\ \hline Software & freely & freely & freely & freely & freely & freely & freely & freely \\ \hline Source-code & GNU & MIT & GNU & not & freely & freely & GNU & freely \\ \hline External & none & none & none & requires & none & none & MySQL, & R \\ \hline Automatic & Yes & No & No & No & No & Yes & Yes & Yes \\ \hline Statistical & Yes & No & No & No & Yes & Yes & No & No \\ \hline Simultaneous & Yes & No & No & No & Yes & Yes & Yes & Yes \\ \hline Statistical & No & No & No & No & Yes & No & No & No \\ \hline Aberration & Yes & No & No & No & Yes & Yes & Yes & Yes \\ \hline Image & Yes & Yes & Yes & Yes & Yes & Yes & Yes & Yes \\ \hline Command- & Yes & No & No & No & No & No & No & No \\ \hline Allows & Yes & Yes & Yes & Yes & Yes & Yes & Yes & Yes \\ \hline Web-linked & No & Yes & Yes & Yes & Yes & Yes & Yes & No \\ \hline \end{tabular} \end{table}

\begin{table} \centering \begin{tabular}{|l||l||l||l||l||l||l||l||l||l||l||l||l|} \hline Caco-2 \\ \hline Gene & Common & Genbank & & 1h & 12h & & 24h & & 48h \\ \hline & & & RT-PCR & Affymetrix & RT-PCR & Affymetrix & RT-PCR & Affymetrix & RT-PCR & Affymetrix \\ \hline matrix & MMP9 & J05070 & na & nd & no & up & na & up & na & na \\ \hline aldo-keto & AKR1C3 & D17793 & na & nd & no & up & up & nd & na & na \\ \hline aquaporin & AQP3 & N74607 & no & down & up & up & up & up & na & na \\ \hline plasminogen & PLAT & M15518 & na & nd & no & nd & no & nd & na & na \\ \hline HMG-box & HBP1 & AF019214 & no & nd & up & up & up & nd & na & na \\ \hline Cox-2* & PTGS2 & U04636 & no & nd & no & nd & down & down & na & na \\ \hline v-erb-b2* & ERBB3 & M34309 & na & nd & up & up & no & nd & na & na \\ \hline proline-rich & PNRC1 & U03105 & na & nd & no & up & up & nd & na & na \\ \hline inhibitor & ID1 & AA457158 & down & down & na & nd & na & nd & na & nd \\ \hline E-cadherin** & CDH1 & Z13009 & na & nd & no & nd & up & nd & no & na \\ \hline hsp27** & HSPB1 & U90906 & na & nd & up & nd & up & nd & no & na \\ \hline p53** & TP53 & U94788 & na & nd & up & nd & no & nd & no & na \\ \hline N-myc & NDRG1 & D87953 & na & nd & up & nd & up & up & up & na \\ \hline NHEK \\ \hline & & & 30 & min & 3h & & 12h & & 24h & & 48h \\ \hline Gene & Common & Genbank & RT-PCR & Affymetrix & RT-PCR & Affymetrix & RT-PCR & Affymetrix & RT-PCR & Affymetrix & RT-PCR & Affymetrix \\ \hline matrix & MMP9 & J05070 & no & nd & no & nd & na & up & na & up & up & nd \\ \hline aldo-keto & AKR1C3 & D17793 & na & nd & down & nd & na & nd & na & nd & down & nd \\ \hline aquaporin & AQP3 & N74607 & no & nd & no & nd & na & nd & na & up & up & nd \\ \hline plasminogen & PLAT & M15518 & no & nd & no & nd & na & nd & na & down & no & nd \\ \hline HMG-box & HBP1 & AF019214 & down & nd & down & nd & na & up & na & nd & no & nd \\ \hline Cox-2* & PTGS2 & U04636 & down & nd & down & nd & na & nd & na & down & down & nd \\ \hline v-erb-b2* & ERBB3 & M34309 & na & nd & down & nd & na & up & na & nd & down & nd \\ \hline proline-rich & PNRC1 & U03105 & na & nd & down & nd & na & up & na & nd & no & nd \\ \hline inhibitor & ID1 & AA457158 & down & down & na & nd & na & nd & na & nd & na & nd \\ \hline E-cadherin** & CDH1 & Z13009 & na & nd & na & nd & no & nd & up & nd & up & nd \\ \hline hsp27** & HSPB1 & U90906 & na & nd & na & nd & up & nd & up & nd & up & nd \\ \hline p53** & TP53 & U94788 & na & nd & na & nd & no & nd & up & nd & up & nd \\ \hline N-myc & NDRG1 & D87953 & na & nd & na & nd & no & nd & no & nd & no & nd \\ \hline \end{tabular} \end{table}

\begin{table} \centering \begin{tabular}{|l||l||l||l|} \hline Protein & CC0189 & CC0569 & CC0331 \\ \hline Length & 88 & 288 & 186 \\ \hline C. & 5e-38 & e-126 & e-102 \\ \hline Other & Mag. & Nov. & Bra. \\ \hline Non-Alpha & Nitro. & Desulf. & Micro. \\ \hline Protein & CC0349 & CC2323 & CC2637 \\ \hline Length & 265 & 377 & 374 \\ \hline C. & e-138 & 0.0 & 0.0 \\ \hline Other & Mag. & Mag. & Mag. \\ \hline Non-Alpha & Staph. & Trep. & Pse. \\ \hline \end{tabular} \end{table}

\begin{table} \centering \begin{tabular}{|l||l||l||l||l|} \hline & Finnish & & Greek \\ \hline & PD & Controls & PD & Controls \\ \hline G & 42.6% & 33.8% & 33.8% & 40.4% \\ \hline G & 17.9% & 23.4% & 17.0% & 19.4% \\ \hline G & 16.1% & 15.7% & 21.4% & 19.4% \\ \hline G & 8.6% & 8.2% & 2.6% & 1.9% \\ \hline G & 8.2% & 5.6% & 9.2% & 8.0% \\ \hline A & 2.4% & 8.3% & 9.6% & 8.2% \\ \hline * & 4.8% & 5.0% & 6.4% & 2.7% \\ \hline \end{tabular} \end{table}

\begin{table} \centering \begin{tabular}{|l||l||l||l|} \hline Element & Description & Content & Content \\ \hline GeneInformation & Contains & Elements & (Name?, \\ \hline AnimalModels & A & Elements & (Animal*) \\ \hline ProteinInformation & Contains & Elements & (ProteinDescription?, \\ \hline ExpressionPattern & Gene & Elements & (Expression*) \\ \hline \end{tabular} \end{table}

\begin{table} \centering \begin{tabular}{|l||l||l||l||l||l|} \hline Endpoint & Significance & Power & Ndiabetic & Nnon-diabetic & N \\ \hline µm & difference \\ \hline & 0.05 & 0.70 & 601 & 601 & 1202 \\ \hline & 0.05 & 0.80 & 764 & 764 & 1528 \\ \hline & 0.05 & 0.90 & 1022 & 1022 & 2044 \\ \hline TPV & 45.9 \\ \hline & 0.05 & 0.70 & 68 & 68 & 136 \\ \hline & 0.05 & 0.80 & 86 & 86 & 172 \\ \hline & 0.05 & 0.90 & 115 & 115 & 230 \\ \hline \end{tabular} \end{table}

\begin{table} \centering \begin{tabular}{|l||l||l||l||l|} \hline & BMD & testing & OP \\ \hline Covariates & Crude & Adjusted & Crude & Adjusted \\ \hline Age \\ \hline 65–69 & 1.00 & - & 1.00 & - \\ \hline 70–74 & 0.97 & 0.96 & 1.42 & 1.46 \\ \hline 75–79 & 0.86 & 0.86 & 1.75 & 1.64 \\ \hline ≥80 & 0.34 & 0.37 & 1.44 & 1.54 \\ \hline Fracture \\ \hline Hip & 1.00 & - & 1.00 & - \\ \hline Humerus & 1.40 & 1.09 & 0.87 & 0.84 \\ \hline Wrist & 1.34 & 1.01 & 0.50 & 0.57 \\ \hline Vertebral & 3.53 & 2.77 & 5.49 & 5.15 \\ \hline Social \\ \hline At & 1.00 & - & 1.00 & - \\ \hline At & 0.79 & 0.81 & 1.33 & 1.27 \\ \hline At & 0.79 & 0.77 & 1.10 & 1.26 \\ \hline Living & 0.05 & 0.08 & - & - \\ \hline Comorbidity & 1.03 & 1.00 & 1.09 & 1.05 \\ \hline Prior & 9.71 & 5.15 & 15.8 & 3.80 \\ \hline Prior & 3.45 & 1.36 & 26.1 & 14.5 \\ \hline Long-term & 5.16 & 2.95 & 7.82 & 2.44 \\ \hline Distance \\ \hline ≤ & 1.00 & - & - & - \\ \hline Between & 1.03 & 0.99 \\ \hline Between & 0.61 & 0.65 \\ \hline More & 0.14 & 0.14 \\ \hline \end{tabular} \end{table}

\begin{table} \centering \begin{tabular}{|l||l|} \hline Medication & Number \\ \hline Carbamazepine & 1 \\ \hline Chlorpromazine & 2 \\ \hline Clozapine & 2 \\ \hline Gabapentin & 1 \\ \hline Haloperidol & 5 \\ \hline Lithium & 13 \\ \hline Olanzapine & 5 \\ \hline Risperidone & 2 \\ \hline Sodium & 2 \\ \hline \end{tabular} \end{table}

\begin{table} \centering \begin{tabular}{|l||l||l||l||l||l|} \hline Indicators & Primary & (n & Secondary & (n & p \\ \hline & Yes & No & Yes & No \\ \hline Difficult & 4 & 45 & 5 & 26 & 0.298 \\ \hline Unable & 16 & 33 & 8 & 23 & 0.515 \\ \hline Asked & 9 & 7 & 2 & 6 & 0.303 \\ \hline Pressed & 42 & 7 & 22 & 9 & 0.108 \\ \hline \end{tabular} \end{table}

\begin{table} \centering \begin{tabular}{|l||l||l||l|} \hline & Prevalence & Nb & Nb \\ \hline All & 22.8 & 104 & 416 \\ \hline Phenacetin-containing & 2.5 & 616 & 2464 \\ \hline MONOS \\ \hline Paracetamol & 5.3 & 308 & 1232 \\ \hline ASA & 15.7 & 129 & 516 \\ \hline Ibuprofen & 2.1 & 728 & 2912 \\ \hline Other & 5.0 & 324 & 1296 \\ \hline COMBIS \\ \hline Paracetamol+caffeine & 0.1 & 14 & 58 \\ \hline Paracetamol+ASA & 0.9 & 1657 & 6628 \\ \hline Paracet+ASA+caffeine & 4.1 & 388 & 1552 \\ \hline Others+caffeine & 0.6 & 2470 & 9880 \\ \hline Other & 3.5 & 449 & 1800 \\ \hline Other & 3.3 & 475 & 1900 \\ \hline Combis & 1.9 & 654 & 2616 \\ \hline \end{tabular} \end{table}

\begin{table} \centering \begin{tabular}{|l||l||l||l|} \hline Biological & No & No & Fisher \\ \hline mitotic & 35 & 136 & 3.840E-22 \\ \hline DNA & 24 & 72 & 3.320E-18 \\ \hline cell & 43 & 307 & 2.360E-16 \\ \hline cell & 46 & 362 & 7.620E-16 \\ \hline DNA & 20 & 61 & 3.770E-15 \\ \hline S & 20 & 62 & 5.400E-15 \\ \hline DNA-dependent & 11 & 24 & 1.160E-10 \\ \hline DNA & 29 & 218 & 1.830E-10 \\ \hline DNA & 7 & 8 & 4.430E-10 \\ \hline mitosis & 12 & 48 & 5.240E-08 \\ \hline M & 12 & 48 & 5.240E-08 \\ \hline cell & 79 & 1411 & 2.740E-07 \\ \hline nuclear & 12 & 58 & 4.950E-07 \\ \hline M & 12 & 61 & 8.830E-07 \\ \hline cellular & 82 & 1564 & 2.770E-06 \\ \hline cytokinesis & 11 & 63 & 8.760E-06 \\ \hline nucleosome & 6 & 21 & 5.920E-05 \\ \hline regulation & 15 & 138 & 7.790E-05 \\ \hline physiological & 135 & 3454 & 6.310E-04 \\ \hline DNA & 9 & 80 & 1.750E-03 \\ \hline Biological & No & No & Fisher \\ \hline microtubule-based & 7 & 64 & 1.340E-03 \\ \hline development & 22 & 456 & 3.400E-03 \\ \hline neurogenesis & 8 & 99 & 4.300E-03 \\ \hline organogenesis & 14 & 243 & 4.390E-03 \\ \hline morphogenesis & 15 & 282 & 6.730E-03 \\ \hline cytoskeleton & 9 & 134 & 8.430E-03 \\ \hline organelle & 10 & 175 & 1.650E-02 \\ \hline cellular & 65 & 2144 & 6.560E-02 \\ \hline cytoplasm & 10 & 222 & 6.720E-02 \\ \hline lipid & 8 & 173 & 8.570E-02 \\ \hline membrane & 3 & 42 & 9.840E-02 \\ \hline cell & 7 & 162 & 1.360E-01 \\ \hline cell & 27 & 835 & 1.440E-01 \\ \hline cell & 12 & 331 & 1.620E-01 \\ \hline regulation & 5 & 110 & 1.650E-01 \\ \hline ion & 7 & 188 & 2.280E-01 \\ \hline cellular & 45 & 1564 & 2.640E-01 \\ \hline cation & 5 & 135 & 2.850E-01 \\ \hline cell & 5 & 144 & 3.330E-01 \\ \hline cell & 9 & 286 & 3.440E-01 \\ \hline \end{tabular} \end{table}

\begin{table} \centering \begin{tabular}{|l||l||l|} \hline & Acupuncture & Placebo \\ \hline Female & 15 & 13 \\ \hline Age & 63.0 & 67.0 \\ \hline Diagnosis \\ \hline breast & 5 & 4 \\ \hline lung & 20 & 16 \\ \hline Breathless & 9 & 6 \\ \hline Credibility & 2.24 & 2.10 \\ \hline Steroid \\ \hline None & 15 & 9 \\ \hline <40 & 6 & 8 \\ \hline 40+ & 4 & 2 \\ \hline Diuretics** & 3 & 0 \\ \hline Opiates** & 5 & 3 \\ \hline Bronchodilators** & 12 & 7 \\ \hline Fully & 8 & 6 \\ \hline \end{tabular} \end{table}

\begin{table} \centering \begin{tabular}{|l||l||l||l||l|} \hline & Gold & Particles & Clathrin & Association \\ \hline Intracellular & GFP-HPS3 & GFP-HPS3-delCBD & GFP-HPS3 & GFP-HPS3-delCBD \\ \hline Small & 57 & 8 & 53 & 1 \\ \hline Golgi & 1 & 1 & 0 & 0 \\ \hline Other & 15 & 16 & 9 & 3 \\ \hline Endosomal & 23 & 17 & 15 & 1 \\ \hline Mitochondria & 2 & 2 & 0 & 0 \\ \hline Melanosomes & 3 & 2 & 0 & 0 \\ \hline Nucleus & 2 & 1 & 0 & 0 \\ \hline Cytoplasm & 8 & 63 & 0 & 3 \\ \hline Total & 111 & 110 & 77 & 8 \\ \hline \end{tabular} \end{table}

\begin{table} \centering \begin{tabular}{|l||l||l||l||l||l||l|} \hline & T1 & T2 & T3 & S1 & S2 & Novel \\ \hline Res1 \\ \hline Mean & 448.72 & 431.74 & 466.39 & 426.04 & 446.69 & 493.62 \\ \hline SD & 3.43 & 1.64 & 14.92 & 3.88 & 6.19 & 0.895 \\ \hline %CV & 0.76 & 0.38 & 3.20 & 0.91 & 1.39 & 0.18 \\ \hline Res2 \\ \hline Mean & 406.67 & 388.46 & 429.92 & 365.63 & 401.16 & 462.28 \\ \hline SD & 2.03 & 1.06 & 17.34 & 7.64 & 5.38 & 0.88 \\ \hline %CV & 0.50 & 0.27 & 4.05 & 2.09 & 1.34 & 0.19 \\ \hline Res3 \\ \hline Mean & 352.59 & 348.85 & 370.44 & 350.61 & 364.09 & 462.87 \\ \hline SD & 0.74 & 0.70 & 0.81 & 2.34 & 3.61 & 5.68 \\ \hline %CV & 0.21 & 0.20 & 0.22 & 0.67 & 0.99 & 1.22 \\ \hline Res4 \\ \hline Mean & 346.10 & 343.44 & 385.33 & 346.83 & 348.42 & 490.10 \\ \hline SD & 0.71 & 0.74 & 1.33 & 0.64 & 1.17 & 0.63 \\ \hline %CV & 0.21 & 0.22 & 0.34 & 0.19 & 0.34 & 0.13 \\ \hline Res5 \\ \hline Mean & 447.03 & 430.49 & 462.51 & 427.14 & 443.69 & 495.41 \\ \hline SD & 1.94 & 0.78 & 17.09 & 3.75 & 2.11 & 1.63 \\ \hline %CV & 0.43 & 0.18 & 3.69 & 0.88 & 0.48 & 0.33 \\ \hline Res6 \\ \hline Mean & 406.05 & 388 & 433.85 & 367.32 & 399.15 & 469.54 \\ \hline SD & 1.89 & 1.01 & 14.64 & 7.04 & 5.93 & 8.41 \\ \hline %CV & 0.47 & 0.26 & 3.38 & 1.92 & 1.49 & 1.79 \\ \hline Res7 \\ \hline Mean & 352.15 & 348.74 & 370.77 & 351.88 & 361.12 & 463.72 \\ \hline SD & 0.48 & 0.44 & 0.92 & 2.07 & 3.29 & 4.58 \\ \hline %CV & 0.14 & 0.13 & 0.25 & 0.59 & 0.91 & 0.99 \\ \hline Res8 \\ \hline Mean & 345.64 & 343.03 & 385.21 & 346.59 & 348.2 & 493.15 \\ \hline SD & 0.58 & 0.70 & 1.36 & 0.60 & 1.48 & 0.70 \\ \hline %CV & 0.17 & 0.20 & 0.35 & 0.17 & 0.42 & 0.14 \\ \hline \end{tabular} \end{table}

\begin{table} \centering \begin{tabular}{|l||l||l||l||l|} \hline & General & Private & Public & Chi2 \\ \hline MHP \\ \hline Having & 64.2 & 55.6 & 64.4 & ns \\ \hline Having & 46.9 & 40.0 & 41.0 & ns \\ \hline Unsatisfactory \\ \hline ... & 19.0 & 33.3 & 29.7 & 0.05 \\ \hline ... & 49.1 & 11.3 & 27.1 & <0.0001 \\ \hline ... & 29.9 & 29.7 & 18.8 & <0.0001 \\ \hline ... & 16.2 & 23.5 & 10.5 & ns \\ \hline Relationships & 53.7 & 15.4 & 8.1 & <0.0001 \\ \hline Having & 39.7 & 93.4 & 77.1 & <0.0001 \\ \hline Scope & 46.3 & 73.2 & 80.7 & <0.0001 \\ \hline General \\ \hline - \\ \hline Independence & 98.9 & 100.0 & 95.2 & ns \\ \hline Exchanges & 99.4 & 88.8 & 98.5 & ns \\ \hline Possibility & 89.9 & 86.3 & 73.3 & 0.008 \\ \hline - \\ \hline Income & 44.8 & 56.8 & 57.7 & ns \\ \hline Administrative & 91.6 & 77.8 & 64.0 & <0.0001 \\ \hline Time & 65.7 & 57.8 & 77.4 & ns \\ \hline Time & 64.4 & 66.7 & 78.1 & ns \\ \hline Opportunities & 84.1 & 85.7 & 80.7 & ns \\ \hline Opportunities & 98.3 & 87.1 & 68.4 & ns \\ \hline \end{tabular} \end{table}

\begin{table} \centering \begin{tabular}{|l||l||l|} \hline Transfer & Adverse & Severity \\ \hline Pulmonary & PaO2 & 3 \\ \hline Oesophageal & Only & 3 \\ \hline Sepsis, & RI; & 2 \\ \hline Imminent & No & 1 \\ \hline Pulmonary & No & 2 \\ \hline ARDS, & SaO2 & 3 \\ \hline Streptococcal & Not & 3 \\ \hline Sleep & SaO2↓ & 3 \\ \hline Haemorragic & No & 3 \\ \hline Infectious & No & 1 \\ \hline Septic & Not & 3 \\ \hline Septic & Norepinephrine & 2 \\ \hline Suicide & Deep & 3 \\ \hline Postsurgical; & Oxygen & 3 \\ \hline COPD, & Shortage & 3 \\ \hline Haemodyalisis & No & 1 \\ \hline Active & Only & 1 \\ \hline ARDS; & Ambulance & 1 \\ \hline \end{tabular} \end{table}

\begin{table} \centering \begin{tabular}{|l||l|} \hline Title & Study \\ \hline AIDS & 1995 \\ \hline AIDS & 2002 \\ \hline AIDS & 1995 \\ \hline American & 1995 \\ \hline Antiviral & 2000 \\ \hline BMC & 2002 \\ \hline Clinical & 1995 \\ \hline Clinical & 1995 \\ \hline Clinical & 2002 \\ \hline Current & 2000 \\ \hline Diagnostic & 1995 \\ \hline Emerging & 1995 \\ \hline Epidemiology & 1995 \\ \hline European & 1995 \\ \hline Infection & 1995 \\ \hline Infection & 1995 \\ \hline Infection & 1995 \\ \hline Infectious & 1995 \\ \hline Infectious & 1995 \\ \hline International & 2000 \\ \hline International & 1997 \\ \hline International & 1995 \\ \hline International & 1998 \\ \hline JAIDS-Journal & 1995 \\ \hline Japanese & 2000 \\ \hline Journal & 1995 \\ \hline Journal & 1995 \\ \hline Journal & 2001 \\ \hline Journal & 1995 \\ \hline Journal & 1997 \\ \hline Leprosy & 1997 \\ \hline Microbial & 1997 \\ \hline Pediatric & 1997 \\ \hline Pediatric & 1995 \\ \hline Scandinavian & 1995 \\ \hline Sexually & 1995 \\ \hline Sexually & 1999 \\ \hline The & 1995 \\ \hline \end{tabular} \end{table}

\begin{table} \centering \begin{tabular}{|l||l||l||l|} \hline Input & Point & Standard & Data \\ \hline Epidemiological \\ \hline Probability & 0.3439 & 0.0123 & 22–24 \\ \hline Probability & 0.2929 & 0.0455 & 1 \\ \hline Proportion & 0.5000 & 0.0498 & Expert \\ \hline Probability & 0.0550 & 0.0010 & 12, \\ \hline Probability & 0.0050 & 0.0003 & 12 \\ \hline Probability & 0.0030 & 0.0017 & Expert \\ \hline Probability & 0.0024 & 0.0004 & 12 \\ \hline Probability & 0.0010 & 0.0010 & Expert \\ \hline Probability & 0.1279 & 0.0358 & 24–26 \\ \hline Utility \\ \hline Utility & 0.80 & 0.02 & 16 \\ \hline Utility & 0.90 & 0.02 & 16 \\ \hline Utility & 0.80 & 0.02 & 16 \\ \hline Utility & 0.89 & 0.01 & 16 \\ \hline \end{tabular} \end{table}

\begin{table} \centering \begin{tabular}{|l||l||l||l||l|} \hline Criteria & 2002 & 2003 & 2004 & Total \\ \hline Haemorrhage & 26 & 30 & 17 & 73 \\ \hline Early & 6(6.5) & 9 & 9 & 24 \\ \hline Ectopic & 6 & 9 & 9 & 24 \\ \hline Abortion & 0 & 0 & 0 & 0 \\ \hline Late & 20 & 21 & 8 & 49 \\ \hline Placenta & 4 & 2 & 2 & 8 \\ \hline Abruptio & 5 & 4 & 2 & 11 \\ \hline Postpartum & 11 & 15 & 4 & 30 \\ \hline Others & 0 & 0 & 0 \\ \hline Hypertension & 32 & 21 & 23 & 76 \\ \hline Eclampsia & 22 & 8 & 9 & 39 \\ \hline Severe & 10 & 13 & 14 & 37 \\ \hline Dystocia & 17 & 19 & 11 & 47 \\ \hline Uterine & 3 & 4 & 3 & 10 \\ \hline Impending & 14 & 15 & 8 & 37 \\ \hline Infections & 9 & 5 & 6 & 20 \\ \hline Anaemia & 8 & 10 & 8 & 26 \\ \hline All & 92 & 85 & 65 & 242 \\ \hline \end{tabular} \end{table}

\begin{table} \centering \begin{tabular}{|l||l||l|} \hline Organ-system & n & Obstetric \\ \hline Cardiac & 3 & Severe \\ \hline & & Severe \\ \hline Coagulation & 1 & Abruptio \\ \hline Renal & 7 & Eclampsia \\ \hline & & Severe \\ \hline & & Septic \\ \hline & & Postpartum \\ \hline Vascular & 7 & Ruptured \\ \hline & & Uterine \\ \hline & & Postpartum \\ \hline Cerebral & 4 & Eclampsia \\ \hline Immunologic & 1 & HIV-related \\ \hline \end{tabular} \end{table}

\begin{table} \centering \begin{tabular}{|l||l||l||l||l||l|} \hline Variable & n & % & Unadjusted & n* & Adjusted \\ \hline Age & 205 & 30.2 & 0.98 & & NA \\ \hline Male & 132 & 35.6 & 1.83 & & NA \\ \hline Hospitalised & 59 & 16.9 & 0.38 & 56 & 0.32 \\ \hline Marital & 125 & 30.4 & 1.01 & & NA \\ \hline Post & 92 & 25.0 & 0.65 & & NA \\ \hline >1 & 207 & 28.5 & 0.47 & & NA \\ \hline Daily & 38 & 51.5 & 2.93 & 34 & 3.70 \\ \hline Subsistence & 28 & 46.4 & 2.22 & 26 & 4.70 \\ \hline Perceived & 34 & 55.9 & 3.63 & 34 & 5.54 \\ \hline >2 & 76 & 13.2 & 0.24 & 72 & 0.15 \\ \hline \end{tabular} \end{table}

\begin{table} \centering \begin{tabular}{|l||l||l||l||l|} \hline Variables & Period & Period & Hazard & Difference \\ \hline Mean & 3.6 & 3.4 & 1.2 & N/A \\ \hline Deaths & 0 & 1 & N/A & -2.7 \\ \hline 14 & 0 & 4 & N/A & -10.8 \\ \hline \end{tabular} \end{table}

\begin{table} \centering \begin{tabular}{|l||l||l||l||l|} \hline & & Time & (hours) \\ \hline Outcome & <0.5 & >4 & >12 & >24 \\ \hline Percent & at \\ \hline Placebo & 75 & 15 & 9.0 & 1.7 \\ \hline Tadalafil & 61 & 23 & 12 & 3.7 \\ \hline Percent & at \\ \hline Placebo & 74 & 15 & 8.4 & 3.3 \\ \hline Tadalafil & 60 & 23 & 13 & 4 \\ \hline Percent & were \\ \hline Placebo & 26 & 26 & 24 & 50 \\ \hline Tadalafil & 65 & 68 & 72 & 74 \\ \hline \end{tabular} \end{table}

\begin{table} \centering \begin{tabular}{|l||l||l||l||l|} \hline Place, & CQ & AQ & SP & Reference \\ \hline Colombia & 82,0 & & & Walker \\ \hline Colombia & 16,4 & 28,3 & 34,7 & Blair \\ \hline Colombia & & & 24,0 & (quoted \\ \hline Colombia & & & 25,0 & (quoted \\ \hline Colombia & 96,0 & 3,3 & & Espinal \\ \hline Antioquia & & & 34,0 & (Restrepo \\ \hline El & 82,0 & 38,0 & 10,0 & Flórez \\ \hline El & 71,0 & 12,0 & 15,0 & López \\ \hline Turbo & 97,0 & 7,0 & 13,0 & Blair \\ \hline Zaragoza & 67,0 & 3,0 & 9,0 & Blair \\ \hline Chocó & 52,0 & & & Comer \\ \hline Quibdó, & 44,0 & & & Osorio \\ \hline Quibdó, & & & 6,0 & Osorio \\ \hline Tadó, & & 27,0 & 16,0 & (González \\ \hline Cali & 78,0 & & & Castillo \\ \hline Buenaventura & & & 3,0 & Méndez \\ \hline Tumaco & 70,0 & 54,0 & & Flórez \\ \hline Tumaco & 40,0 & 18,0 & 0,0 & Flórez \\ \hline Tumaco & & 50,0 & 15,3 & González \\ \hline El & & 0,0 & 0,0 & González \\ \hline Orinoquía & & & (3) & Espinal \\ \hline Average & 66,3 & 21,9 & 14,6 \\ \hline Mean & 70,0 & 19,9 & 14,6 \\ \hline \end{tabular} \end{table}

\begin{table} \centering \begin{tabular}{|l||l||l||l||l||l||l||l||l||l|} \hline Response & CQ & AQ & MQ & SP & CQ-SP & AQ-SP & MQ-SP & AS-SP & Total \\ \hline Early & 8 & 2 & 1 & 12 & 1 & 1 & 0 & 1 & 26 \\ \hline % & 47.1 & 6.1 & 1.1 & 15.2 & 1.6 & 1.1 & 0.0 & 1.7 & 5.3 \\ \hline Late & 6 & 8 & 3 & 7 & 10 & 1 & 0 & 1 & 36 \\ \hline % & 35.3 & 24.2 & 3.3 & 8.9 & 15.6 & 1.1 & 0.0 & 1.7 & 7.4 \\ \hline Total & 14 & 10 & 4 & 19 & 11 & 2 & 0 & 2 & 62 \\ \hline % & 82.4 & 30.3 & 4.4 & 24.1 & 17.2 & 2.2 & 0.0 & 3.4 & 12.7 \\ \hline Adequate & 3 & 23 & 88 & 60 & 53 & 88 & 55 & 55 & 425 \\ \hline % & 17.6 & 69.7 & 95.6 & 75.9 & 82.8 & 97.8 & 100.0 & 96.6 & 87.3 \\ \hline Total & 17 & 33 & 92 & 79 & 64 & 90 & 55 & 57 & 487 \\ \hline % & 100.0 & 100.0 & 100.0 & 100.0 & 100.0 & 100.0 & 100.0 & 100.0 & 100.0 \\ \hline \end{tabular} \end{table}

\begin{table} \centering \begin{tabular}{|l||l||l||l||l|} \hline Entry & Sulfur & other & Yieldb & diastereoselectivity \\ \hline 1 & 4 & --- & 72 & 37:14:49 \\ \hline 2 & 5 & --- & 62 & 80:16:4 \\ \hline 3 & (+)-1 & --- & 63 & 89:5:6 \\ \hline 4 & (+)-1 & LiCl & 64 & 96:0:4 \\ \hline 5 & (-)-1 & --- & 56 & 1:21:78 \\ \hline 6 & (-)-1 & LiCl & 61 & 2:32:66 \\ \hline 7 & (+)-11 & --- & 49 & 53:33:14 \\ \hline 8 & (-)-11 & --- & 52 & 52:42:6 \\ \hline \end{tabular} \end{table}

\begin{table} \centering \begin{tabular}{|l||l||l||l||l||l||l|} \hline & Excess & mortality & numbers & Index & Excess & in \\ \hline Winter & Males & Females & Total & Males & Females & Total \\ \hline 1996/1997 & 110,5 & 89 & 199,5 & 18 & 18 & 18 \\ \hline 1997/1998 & 12 & 58,5 & 70,5 & 1 & 11 & 6 \\ \hline 1998/1999 & 45 & 69 & 114 & 6,6 & 13,1 & 9,5 \\ \hline 1999/2000 & 130,5 & 213,5 & 344 & 19,7 & 44,1 & 30 \\ \hline Total & 298 & 430 & 728 & 11.3 & 21.5 & 15,9 \\ \hline \end{tabular} \end{table}

\begin{table} \centering \begin{tabular}{|l||l||l|} \hline Drug & Iban & Iban \\ \hline 50% & 1.0 & 0.9 \\ \hline Combination & Additive & Additive \\ \hline 75% & 1.1 & 1.0 \\ \hline Combination & Additive & Additive \\ \hline \end{tabular} \end{table}

\begin{table} \centering \begin{tabular}{|l||l||l||l|} \hline Exon & Oligonucleotide & PCR & Restriction \\ \hline 01a & CGGTATCCCTACTCTCAGCCA/GCGGGATCCAGCCAGG & 164 & - \\ \hline 01b & GGTGCGAAAAGAAATGCA/CACTGGCTCGCCTGCC & 202 & - \\ \hline 02 & CTCTTGTGTGTCTGTGTGCCT/ & 403 & AvaII \\ \hline 03 & GACTTCCCTATTTCCCCCAT/TCTCGGAGAAGAGGAGGCT & 207 & - \\ \hline 04 & TGAAGGTGTCTCCATGCAAC/AGAAGGGCATGTGGTCTAAGA & 275 & BsmFI \\ \hline 05 & CTGATGAGGCCGTAAGGATA/GTGGATTGACCCCAACACT & 280 & Eco24I \\ \hline 06 & TCCATAACTCTTACCCCCGT/CTGGGTACGCAAGGTAAGG & 255 & MboII \\ \hline 07 & CCTGATTTCTGGCTCCTGAC/CCTCTATCTACATGCCAGCCT & 209 & - \\ \hline 08 & GCTGAGCTGTGACCTTTGAGT/TCTCGGAGAAGAGGAGGCT & 199 & - \\ \hline 09 & CTCCTCTCTTCCCTGCCAT/CCTCATAGCACTCCCCACC & 199 & - \\ \hline 10 & CTCAATCCCCTTCTCCCAC/AGTGTGAGAAGCACCACGTC & 209 & - \\ \hline Promoter \\ \hline Sys1 & GGGCTTAATTCGACCCAA/GCATTTCTTTTCGCACC & 213 & - \\ \hline Sys2 & GCTAACAGGCCGGAGGAGA/GGATTGATCGGAGGATTAGCT & 212 & - \\ \hline Sys3 & CTCTCCTTTCCCGGTTTG/TCGTCTAGTTGGAAACCGAG & 234 & - \\ \hline Sys4 & CTCTTTATCCCGAACCACCT/TCTCGCGGGATCTAAAGG & 221 & - \\ \hline Sys5 & CATCACGCTGACCAGAGG/TGGTGAAAGATTAGTGTCCCA & 214 & - \\ \hline \end{tabular} \end{table}

\begin{table} \centering \begin{tabular}{|l||l||l||l|} \hline MGD & Transcripts & Catalytic & Accessory \\ \hline B230120H23Rik & AB049732 & + & SAM, \\ \hline Bmp2k & AK046752 & + & IPR011051 \\ \hline Camk2d & AK032524 & + & NTF2 \\ \hline Dcamkl1 & AK032424 & + & Doublecortin \\ \hline Ddr2 & AK132504 & + & Ligand \\ \hline Irak2 & AY162380 & + & Death \\ \hline Jak1 & BC031297 & + & SH2, \\ \hline Map3k14 & AF143094 & & omega \\ \hline Mapk8 & AB005663 & + & H+ \\ \hline Mast1 & AK141034 & + & PDZ \\ \hline Pik3r4 & AK042361 & + & ARM \\ \hline Plk4 & AK045082 & + & C-terminal \\ \hline Ppm1a & AF369981 & + & SSF81601 \\ \hline Prkx & AK039088 & + & Protein \\ \hline Ptpn21 & D83072 & + & Band4.1/Ferm \\ \hline Ptprb & AF157628 & + & Ligand \\ \hline Ptprd & BC025145 & + & Ligand \\ \hline Ptpre & U36758 & + & Ligand \\ \hline Ptprg & AK144283 & + & Ligand \\ \hline Ptprs & AK159320 & + & Ligand \\ \hline Ptpro & U37466 & + & Ligand \\ \hline Rps6kc1 & BC058403 & + & MIT, \\ \hline Stk36 & AK007188 & + & ARM \\ \hline Tns1 & AK053112 & + & SH2 \\ \hline Zap70 & AB083210 & + & SH2 \\ \hline \end{tabular} \end{table}

\begin{table} \centering \begin{tabular}{|l||l||l||l||l|} \hline & Aorta & & Mesenteric & artery \\ \hline & C & GK & C & GK \\ \hline MMP-2 & ↑10* & No & ↑11* & ↓3** \\ \hline MMP-9 & ↑3* & No & ↑10* & ↓2** \\ \hline MT1-MMP & ↑6* & No & ↑7* & ↓7** \\ \hline COL1A1 & ↑27* & No & ↑7* & ↓8** \\ \hline Fibronectin & ↑1.23 & ↓1.25 & ↑9* & ↓3** \\ \hline c-Fos & ↓3* & ↑2 & ↓3* & ↑2** \\ \hline c-Jun & ↑3* & No & ↑3* & ↓5** \\ \hline \end{tabular} \end{table}

\begin{table} \centering \begin{tabular}{|l||l||l||l||l||l|} \hline Clinical & HbSS & HbSC & HbSβ0 & HbSβ+ & Sickle \\ \hline Age & 26.4 & 27 & 25.9 & 26.5 & 25.1 \\ \hline †Gender & 71:77 & 38:47 & 2:4 & 13:9 & 4:1 \\ \hline µmol/L & 45.7 & 63.3 & 70.7 & 61.9 & 62 \\ \hline #Uric & 0.3 & 0.3 & 0.4 & 0.4 & 0.3 \\ \hline #Haemoglobin & 80.2 & 108.2 & 91.6 & 109.9 & 124 \\ \hline #Nucleated & 15.9 & 10.2 & 13.3 & 9.2 & 9.9 \\ \hline ≥ & 17 & 7 & 0 & 1 & 0 \\ \hline †Positive & 2 & 2 & 0 & 0 & 0 \\ \hline †Positive & 50 & 25 & 2 & 1 & 1 \\ \hline \end{tabular} \end{table}

\begin{table} \centering \begin{tabular}{|l||l||l||l||l||l||l||l||l|} \hline Subject & Age & Sex & Clinical & ECG & RV & Pathological & Major & Minor \\ \hline II:4 & 44 & F & Asymptomatic & T & None & Not & 0 & 2 \\ \hline II:7 & 44 & F & Palpitations & T & Mild & Not & 0 & 3 \\ \hline III:2 & 16 & M & Palpitations & T & Dilated & Not & 2 & 2 \\ \hline III:3 & 13 & F & Palpitations & VT & Dilated & Not & 1 & 2 \\ \hline III:4 & 23 & M & Palpitations, & T-wave & Dilated & Fibrofatty & 1 & 4 \\ \hline III:6 & 21 & M & Asymptomatic & & Dilated & Not & 1 & 2 \\ \hline III:7 & 19 & F & Syncope & Frequent & Dilated & Not & 1 & 4 \\ \hline III:9 & 16 & F & Asymptomatic & None & Mild & Not & 0 & 2 \\ \hline \end{tabular} \end{table}

\begin{table} \centering \begin{tabular}{|l||l||l||l||l||l|} \hline Gene & Genomic & No. & Flanking & Function & Variants \\ \hline ITGA8 & 0.20 & 30 & D10S1477, & The & 133C>A \\ \hline FRMD4A & 0.69 & 25 & D10S1664, & This & CA \\ \hline LAMR1P6 & 0.884 & 1 & D10S600, & There & 346G>A \\ \hline \end{tabular} \end{table}

\begin{table} \centering \begin{tabular}{|l||l||l||l||l||l||l||l||l||l||l|} \hline & A & & & & & & B \\ \hline Chromoso & Up & & Down & & Up+Down & & Up & & Down \\ \hline & Total & % & Total & % & Total & % & Banding & % & Banding & % \\ \hline 1 & 33 & 1.02 & 54 & 1.68 & 87 & 2.70 & & & 1q21.3 & 3.12 \\ \hline 2 & 11 & 0.75 & 28 & 1.90 & 39 & 2.65 & & & 2p11.2 & 6.66 \\ \hline 3 & 11 & 0.55 & 58 & 2.89 & 69 & 3.43 & 3p21.31 & 4.03 & 3p21.31 & 3.14 \\ \hline 4 & 38 & 2.26 & 46 & 2.73 & 84 & 4.99 & & & 4q13.3 & 9.37 \\ \hline 5 & 4 & 0.67 & 8 & 1.35 & 12 & 2.02 & & & 5q33.1 & 6.58 \\ \hline 6 & 14 & 1.22 & 36 & 3.15 & 50 & 4.37 & 6p21.31 & 6.33 \\ \hline 7 & 11 & 1.05 & 19 & 1.81 & 30 & 2.86 & & & 7q21.3 & 8.93 \\ \hline 8 & 18 & 1.25 & 30 & 2.08 & 48 & 3.34 \\ \hline 9 & 31 & 1.69 & 39 & 2.13 & 70 & 3.82 & & & 9q34.11 & 3.60 \\ \hline 10 & 5 & 1.05 & 10 & 2.10 & 15 & 3.15 \\ \hline 11 & 30 & 1.32 & 46 & 2.03 & 76 & 3.36 & & & 11p15.1 & 7.81 \\ \hline 12 & 25 & 1.14 & 61 & 2.78 & 86 & 3.91 & 12q13.13 & 4.80 & 12q13.13 & 7.20 \\ \hline 13 & 19 & 1.76 & 21 & 1.94 & 40 & 3.70 \\ \hline 14 & 5 & 1.27 & 8 & 2.03 & 13 & 3.29 & 14q11.2 & 2.59 & 14q11.2 & 2.59 \\ \hline 15 & 7 & 0.84 & 16 & 1.93 & 23 & 2.77 \\ \hline 16 & 19 & 1.08 & 40 & 2.28 & 59 & 3.36 & 16p11.2 & 3.10 & 16p11.2 & 3.10 \\ \hline 17 & 9 & 0.74 & 38 & 3.14 & 47 & 3.88 & 17q21.2 & 5.71 & 17q21.2 & 5.00 \\ \hline 18 & 12 & 0.86 & 31 & 2.22 & 43 & 3.08 \\ \hline 19 & 14 & 0.80 & 29 & 1.65 & 43 & 2.44 & 19p13.3 & 2.43 & 19p13.11 & 2.15 \\ \hline 20 & 10 & 0.56 & 38 & 2.13 & 48 & 2.69 & & & 20q13.12 & 2.92 \\ \hline 21 & 8 & 0.70 & 25 & 2.18 & 33 & 2.87 & 21q22.3 & 3.12 & 21q22.3 & 3.75 \\ \hline 22 & 17 & 1.20 & 31 & 2.19 & 48 & 3.40 \\ \hline X & 21 & 1.59 & 31 & 2.34 & 52 & 3.93 & Xq28 & 4.76 \\ \hline Y & 1 & 0.64 & 1 & 0.64 & 2 & 1.27 \\ \hline \end{tabular} \end{table}

\begin{table} \centering \begin{tabular}{|l||l||l||l||l||l||l|} \hline & & & aMRSA & & bMSSA \\ \hline Source/Specimen & N & % & N & % & N & % \\ \hline Wounds & 922 & 37.9 & 271 & 60.1 & 651 & 32.9 \\ \hline Pus/abscess & 368 & 15.1 & 30 & 6.6 & 338 & 17.1 \\ \hline Upper & 283 & 11.6 & 0 & - & 283 & 14.3 \\ \hline Urine & 232 & 9.5 & 70 & 15.5 & 84 & 4.2 \\ \hline Blood & 201 & 8.3 & 28 & 6.2 & 73 & 8.7 \\ \hline Lower & 109 & 4.5 & 25 & 5.5 & 84 & 4.2 \\ \hline Eye & 95 & 4.0 & 5 & 1.1 & 90 & 4.5 \\ \hline Ear & 71 & 3.0 & 8 & 1.8 & 63 & 3.2 \\ \hline High & 66 & 2.7 & 13 & 2.9 & 53 & 2.7 \\ \hline Cerebrospinal & 29 & 1.2 & 0 & - & 29 & 1.5 \\ \hline dMiscellaneous & 54 & 2.2 & 1 & 0.2 & 53 & 2.7 \\ \hline Total & 2430 & 100 & 451 & 100 & 1979 & 100 \\ \hline \end{tabular} \end{table}

\begin{table} \centering \begin{tabular}{|l||l||l||l||l|} \hline Variable & Heterosexual & Bisexual & Lesbian & Chi2, \\ \hline SmokingM & 294 & 48 & 15 & 28.27 \\ \hline SF12 & 233 & 23 & 6 & 0.29 \\ \hline GHQ & 371 & 40 & 11 & 1.78 \\ \hline CAGE & 164 & 35 & 8 & 29.37 \\ \hline More & 28 & 8 & 1 & 9.32 \\ \hline Any & 567 & 51 & 14 & 0.53 \\ \hline Childhood & 112 & 27 & 4 & 25.72 \\ \hline Dissatisfied & 462 & 46 & 16 & 1.98 \\ \hline Consultations & 186 & 13 & 5 & 0.83 \\ \hline \end{tabular} \end{table}

\begin{table} \centering \begin{tabular}{|l||l||l||l||l||l||l||l||l||l||l||l|} \hline Clone & & Plate & & Sequence & of & CelF & Codons & & & pH & 50°C, \\ \hline & Mutagenesis & & & & NNR & NNR & NNR & NNR & * \\ \hline WT & & From & AAT & GCT & AGA & CCA & GGA & TTC & TAA & 5.0–5.8 & Moderate \\ \hline & & & Asn & Ala & Arg & Pro & Gly & Phe & * \\ \hline #62 & & From & AAT & GCT & CCA & GTA & CGG & GAA & TAA & 5.0–5.8 & Moderate \\ \hline & & & Asn & Ala & Pro & Val & Arg & Glu & * \\ \hline COLONY & PICKING & & & Variants & with & High & at & pH \\ \hline MAN & AUTO \\ \hline E7 & & From & AAT & GCT & TTA & TAA & & & & 4.0–5.8 & Not \\ \hline & & & Asn & Ala & Leu & * \\ \hline F2 & G12 & From & AAT & GCT & CAA & TGG & ACA & CCA & TAA & 4.0–5.8 & Moderate \\ \hline & & & Asn & Ala & Gln & Trp & Thr & Pro & * \\ \hline φ & φ & From & AAT & GCT & ATG & CCA & ACG & TTA & TAA & 4.0–5.8 & Very \\ \hline & & & Asn & Ala & Met & Pro & Thr & Leu & * \\ \hline F12 & & From & AAT & GCT & CCA & TAA & & & & 4.0–5.8 & Moderate \\ \hline & & & Asn & Ala & Pro & * \\ \hline HTS & Mutagenesis & & & & NNR/Y & NNR/Y & NNR/Y & NNR/Y & * \\ \hline & C7 & From & AAT & GCT & GGG & TTA & GAA & TAG & TAA & 4.0–5.8 & Very \\ \hline & & & Asn & Ala & Gly & Leu & Glu & * & * \\ \hline \end{tabular} \end{table}

\begin{table} \centering \begin{tabular}{|l||l||l||l||l||l||l|} \hline e-value & 10-1 & 10-2 & 10-3 & 10-4 & 10-5 & 10-6 \\ \hline exact & 9473 & 7772 & 6271 & 4563 & 3232 & 2348 \\ \hline Karlin & 3417 & 2047 & 1056 & 439 & 195 & 96 \\ \hline accuracy & 34% & 26% & 17% & 10% & 6% & 4% \\ \hline \end{tabular} \end{table}